Health facilities in Lithuania are obliged to get connected to the electronic patient care system since 2018.

The Robert Car civil society Networks Fund (RCNF) is the first international pooled funding mechanism that specifically aims to strengthen global and regional HIV civil society and community networks across the world. This institutional focus is in recognition of networks’ critical value and contribution to better health, inclusion ...

Global HIV Prevention Coalition holds first meeting in Geneva, Switzerland, to find ways to strengthen and sustain political commitment for HIV prevention As part of global efforts to end AIDS as a public health threat, UNAIDS, the United Nations Population Fund (UNFPA) and partners have launched ...

The World Heath Organization and UNAIDS have announced approval of a revolutionary pricing agreement that will facilitate access to the first affordable and all-purpose single-pill HIV regimen including Dolutegravir (DTG) for the public sector in low and middle-income countries. Its price will be around 75 ...

Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single-tablet regimen (STR), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with ...

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. Plans are under way to try the so-called trispecific antibody in initial human trials before the end of 2018, ...

To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Methods: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who initiated raltegravir or dolutegravir between 2006 and 2015 were investigated concerning treatment modification within the first ...

A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to ...

One of the most vulnerable populations that is often overlooked when it comes to treating and preventing HIV is older adults. Prior research has demonstrated that stigma due to age is common among older Americans living with HIV, which can often intensify transmission of the virus. According to ...

The aim of the study was to assess, among people living with HIV, knowledge of their latest HIV viral load (VL) and CD4 count. Methods Agreement between self-report and clinic record was assessed among 2771 HIV-diagnosed individuals on antiretroviral treatment (ART) in the UK Antiretrovirals, Sexual Transmission ...

On September 6, in Poland, the ECUO held a working meeting jointly with the international experts, representatives of governmental institutions and activists of PLHIV communities, to discuss the new concept of access to innovative treatment. You can review the concept here. Without exaggeration, it is a landmark meeting that took place on the edge of two Europes: East and West. In West Europe, the epidemic is brought under control already, so HIV-infected people have an opportunity ...

HIV-positive U.S. residents in the large NA-ACCORD cohort had an atherosclerotic myocardial infarction (MI) rate 20% higher than people in a U.S. general-population cohort, newly published data reveal. This 29,169-person analysis also linked MI risk to lower CD4 count, higher viral load and a host ...

The World Health Organization (WHO) and UNAIDS have released a joint statement on HIV testing services that reinforces two key principles that ensure a human rights-based and public health approach to HIV testing. The statement says that HIV testing, no matter how it is delivered, must always respect ...

Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions — infectious particles — to be connected to infectivity. The findings, published in Proceedings of the National Academy of Sciences, could help lead to the development of novel therapies for HIV ...

President of the ECUO Vladimir Zhovtyak talks, in his blog, about the main issues to be discussed at the working meeting of the ECUO communities, which will be held on the 6th of September in Poland. During the first working week of autumn, representatives of ECUO ...

PARIS — The last time the International AIDS Society Conference on HIV Science met in 2003, fewer than 2 million people globally were on HIV treatment. As the event returned to Paris this week, UNAIDS reported 19.5 million people are now taking antiretroviral therapy, or ART. The numbers put ...

Extension of 2013 agreement allows an additional 1.4 million people living with HIV to benefit from sublicensed generics of World Health Organization-recommended antiretroviral. Paris, 25 July 2017 — The Medicines Patent Pool (MPP) has signed an extension of its licensing agreement with biopharmaceutical company Bristol-Myers Squibb ...

HVTN 705 vaccine study passes its “go” criteria: due to start this autumn A year ago, one of the biggest pieces of prevention news at the Durban International AIDS Conference was the announcement that a large HIV vaccine efficacy study would start in South Africa. HVTN 702, ...